ProQR and Ginkgo Bioworks to collaborate on autonomous lab high throughput data generation to support ProQR’s AI-enabled drug discovery for Axiomer™ProQR establishes AI Advisory Board with leaders from industry and academiaProQR’s first AI-discovered Development
… newly formed Wings Therapeutics created by EB Research Partnership LEIDEN, Netherlands and CAMBRIDGE, Mass., March … Wings Therapeutics is formed and financed by EB Research Partnership (EBRP), the largest global non-profit dedicated …
Partnership focused on utilizing Axiomer™ to develop editing oligonucleotides targeting an underlying genetic variant that causes Rett syndromeCollaboration expands ProQR’s commitment to advance the development of therapies for central nervous system diseases
… into mid-2026 following Eli Lilly milestone related to partnership expansion Virtual R&D event today at 10:00 am … as well as research related to ongoing discovery efforts. Partnerships: ProQR will continue to execute on its existing … with Lilly. Additionally, ProQR may selectively form new partnerships, which could include multi-target discovery …
… milestones achieved in H1 related to progress in the Lilly partnership €96.2 million cash position as of end of Q2 … mid-2026, plus additional potential milestones from Lilly partnership LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 08, … first half of the year. With the benefits of a productive partnership, a differentiated pipeline strategy rooted in …
… of Axiomer™ for CNS applications via new research partnership with Rett Syndrome Research Trust Completed … 2024 along with potential milestone income from existing partnership, and potential option to exercise for expansion … opt-in payment to ProQR. ProQR may selectively form new partnerships, which could include multi-target discovery …
